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Abstract
Mechanisms by which HIV affects the thymus are multiple and only partially known, and the role of thymic dysfunction in
HIV/AIDS immunopathogenesis remains poorly understood. To evaluate the effects of HIV infection on intra-thymic
precursors of T cells in HIV-infected adults, we conducted a detailed immunophenotypic study of thymic tissue isolated
from 7 HIV-infected and 10 HIV-negative adults who were to undergo heart surgery. We found that thymuses of HIV-
infected individuals were characterized by a relative depletion of CD4+ single positive T cells and a corresponding
enrichment of CD8+ single positive T cells. In addition, thymocytes derived from HIV-infected subjects showed increased
levels of activated and proliferating cells. Our analysis also revealed a decreased expression of interleukin-7 receptor in early
thymocytes from HIV-infected individuals, along with an increase in this same expression in mature double- and single-
positive cells. Frequency of regulatory T cells (CD25+FoxP3+) was significantly increased in HIV-infected thymuses,
particularly in priorly-committed CD4 single positive cells. Our data suggest that HIV infection is associated with a complex
set of changes in the immunophenotype of thymocytes, including a reduction of intrathymic CD4+ T cell precursors,
increased expression of activation markers, changes in the expression pattern of IL-7R and enrichment of T regulatory cells
generation.
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Introduction
HIV infection initiates a series of complex events culminating in
profound immunosuppression caused by functional abnormalities
and quantitative depletion of CD4+ T lymphocytes. The
mechanism(s) responsible for the progressive CD4 cell count
decline seen in untreated HIV infection remain a matter of
controversy [1–4]. Current observations suggest that direct
infection of target cells is only partially responsible for T-cell
depletion. A more complex model which also includes alterations
in immune activation, T-cell turnover and homeostatic regulation,
is now favoured [5–8].
HIV infection leads to sustained immune activation and to
major alterations in T cell homeostasis [9–13]. In particular,
naive cells, CD4 and CD8 alike, are progressively depleted,
possibly as a consequence of their frequent activation and
differentiation into memory cells caused by chronic and high
antigenic stimulation.
The thymus is the primary organ of thymopoiesis and is highly
active during early life. While thymic function may not be
necessary after puberty in most individuals, significant thymocyte
and T cell depletion can occur as a result of chemotherapy, bone
marrow transplant or HIV infection. In each of these three
scenarios, the thymus is required to play a significant role in
achieving complete immune recovery [14–17].
Impairment of thymic T-cell production in AIDS pathogenesis
was originally proposed following studies which demonstrated
destruction of thymic structure, lack of thymocytes and infiltration
of activated cells in thymuses of AIDS patients [18–19].
Measurement of TCR rearrangement excision circles (TREC),
used to assess thymic output in individuals with HIV infection, has
failed to produce clear conclusions. Douek and collaborators
found decreased T cell TREC content and reduced proportions of
naı¨ve T cells during early HIV infection, resulting from a
combination of increased T cell proliferation and decreased
thymic output [20]. It is not possible to distinguish the true effects
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of peripheral events such as T cell activation and expansion on
CD4+ TREC content, either during HIV infection or during
antiretroviral induced immune-reconstitution. For this reason,
caution in interpreting TREC assay is required [21]. Dion and
coworkers studied an alternate sj/bTREC ratio which directly
reflects precursors cell proliferation in the thymus, thereby
avoiding confusion caused by peripheral T cell division. They
revealed that HIV infection disrupts the development of T cells
early in the course of disease progression, and that this thymic
defect is partly compensated in the periphery during the same
period. Increased DbJb TREC frequencies point to a reduced role
of the virus in cell death, with a major part being played instead by
cytokine-mediated inhibition [22]. Studies on SIV-infected rhesus
macaques revealed minimal impact from thymectomy on the
peripheral T-cell compartment [Picker, unpublished data], despite
a lack of an extrathymic source of naı¨ve T cells [23].
Our ex-vivo study was aimed at an in-depth analysis of the effect
of HIV infection on intra-thymic precursor T cells. In particular,
thymic tissue of HIV-infected patients were phenotypically studied
to evaluate the effect of HIV infection on thymic precursors of
CD4+ T cells. The potential role of proliferation and immune
activation was also considered by evaluating the impact of
peripheral immune activation on thymocytes. Given IL-7’s
essential role in early human T-cell development and homeostasis
[24–26], we considered it important to evaluate the expression of
IL-7 receptor on thymic cells of both HIV-infected and uninfected
subjects. Moreover, since regulatory T cells (Treg) develop in the
thymus [27] and are critical for the control of immune responses
[28], we analyzed the impact of HIV on the development of
CD4+CD25+ T cells in the thymus.
Methods
Study design
We performed a cross-sectional, observational, institutional
review board-approved study (Institute of Infectious Diseases,
Luigi Sacco Hospital, Milan) of HIV-infected and HIV-negative
adult donors undergoing cardiac surgery for coronary disease or
cardiac valve disease at Luigi Sacco Hospital, University of Milan.
Seven HIV-infected and 10 age-matched HIV-negative adult
donors were enrolled at the Institute of Infectious and Tropical
Diseases, Luigi Sacco Hospital, University of Milan (table 1).
Thymic tissues were collected during cardiac surgery in adult
patients. Patients participating in this study gave written informed
consent according to the Declaration of Helsinki. Adult donors
with autoimmune diseases or donors treated with immunosup-
pressive drugs were excluded.
Tissue collection and cell preparation
Immediately after surgery, thymus tissue was separated from the
fibrotic capsule and from visible blood-vessels, mechanically
disaggregated using a scalpel and scissors followed by pipetting
several times with phosphate buffered saline (PBS). A single-cell
suspension from the thymus was obtained by gently passing the
collected PBS and tissue fragments through a sterile 70 mm
stainless-steel sieve. Cell suspensions were centrifuged and fatty
debris was discarded.
Freshly isolated cells from each sample were filtered through a
50 mm sterile nylon mesh and examined by means of flow
cytometry.
All steps were performed in asepsis using sterile PBS containing
0.1% bovine serum albumin.
Flow cytometry
Flow cytometry was performed using a FACScan flow
cytometer (FC500 Beckman Coulter Miami, FL). Cells were
analysed immediately after immunostaining using forward-scatter
and side-scatter signals to establish the thymocyte gate and to
exclude dead cells, debris and cell clumps. Fluorescence signals
were collected in log mode. A minimum of 50.000 cells of interest
were acquired for each sample and data were analysed using CXP
analysis software. Immunostaining was performed using conjugat-
ed monoclonal antibodies (mAbs) to: CD1a, CD3, CD4, CD8,
CD27, CD34, CD69, CD127 (IL-7 receptor a-chain), CCR5,
CXCR4, Ki67, TCRab and TCRcd, CD25, FoxP3 (Becton
Dickinson Biosciences, San Jose, CA and Beckman Coulter,
Miami, FL). The mAbs were conjugated with fluorescent dyes
fluorescein-isothiocyanate (FITC), phycoerythrin (PE), phycoery-
thrin-texas-red (ECD), phycoerythrin-cyanin-7 (PC7), phycoery-
thrin-cyanin-5 (PC5) and appropriately combined to assess the
thymic cell subset of interest in five-colour fluorescence assays.
Irrelevant isotypic mAbs were used as negative control.
Different phenotypes were used to evaluate thymopoiesis:
CD34+CD1a-; CD34+CD1a+; CD3-CD4-CD8- (triple negative,
TN); CD3-CD4+CD8- (immature single positive CD4+, ISP4+);
CD3-CD4+CD8+ (CD3- double positive,CD3-DP); CD3+CD4+
CD8+ (CD3+ double positive, CD3+DP); CD3+CD4+CD8- (single
positive, SP CD4+); CD3+CD4-CD8+ (single positive, SP CD8+)
(figure 1).
Statistical analysis
Comparisons between HIV-positive and HIV-negative patients
were made using a Mann-Whitney U-test. Correlation analysis
was made using a non-parametric test. Statistical analysis was
performed using the SAS statistical package.
Table 1. HIV-infected subjects characteristics at thymectomy.
Patient Age (years) Sex CDC stage
CD4+ T cells
(cells/ml)
Plasma HIV-RNA
log10 (cp/ml) ARV therapya
1 32 M A2 618 4.89 none
2 41 M A1 509 5.02 none
3 51 F A3 763 1.69 ddC+AZT
4 48 M A2 481 4.59 none
5 43 M C3 328 1.69 3TC+DRV/r+RAL
6 42 F B3 40 4.20 none
7 53 M C3 379 1.69 FTC+TDF+DRV/r+RAL
acurrent antiretroviral therapy.
doi:10.1371/journal.pone.0010788.t001
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Results
Flow cytometry evaluation of thymopoietic stages
Phenotypic subpopulation analysis was performed on input
cells using multiparameter flow cytometry. Percentages of
CD34+CD1a- and CD34+CD1a+ thymocytes were similar in
the two groups and represented the smallest proportions of
thymocytes, where CD34+CD1a- were 0.04-2.5% of cells in the
HIV-infected group and 0.02–4% in uninfected controls and
CD34+CD1a+ were 0.1–0.13% of cells in HIV-infected thymuses
and 0.1–1.3% in uninfected controls. Percentages of triple
negative and immature single positive CD4+ cells (CD3-
CD4+CD8- cells) did not significantly differ in HIV-infected and
HIV-negative subjects (TN: HIV+ 49.8%; HIV- 29%; ISP4+:
HIV+ 4.6%; HIV- 4.15%), indicating a normal presence of
intrathymic precursors in HIV-infected thymuses (figure 2).
T cells actively undergoing thymopoiesis show moderate CD3
expression. Bright CD3 expression is a hallmark of mature T cells
which are either preparing to emigrate or are residing in the
perivascular space of the thymus. Frequency of CD3-low cells in
HIV-infected individuals was 71%; this result was similar to that
observed in HIV-negative subjects (67%), confirming the presence
of active thymopoiesis in thymic tissue of both groups.
Another measure of thymopoiesis is frequency of CD4+CD8+
double-positive T cells. Compared to HIV-uninfected individuals,
HIV-infected subjects had lower levels of CD4+CD8+ double-
positive cells (CD3-low DP HIV+ 33.5%; HIV- 50.5%; CD3-
bright DP HIV+ 23%; HIV- 31.05%).
In evaluating single positive cells, we found lower expressions of
CD4+ single positive cells in HIV-infected patients in comparison
to HIV-negative subjects (HIV+ 13.9%; HIV- 37.7%). Converse-
ly, HIV+ subjects displayed gher levels of CD8+ single positive
cells than uninfected controls (HIV+ 46%; HIV- 22.5%).
To characterize the imbalance between CD4+ SP and CD8+
SP T cells in the two groups of subjects, we calculated the CD4+
SP/CD8+ SP ratio. The comparison of HIV-infected with healthy
thymuses controls showed significantly lower levels of CD4+ SP/
CD8+ SP T cells in the HIV-infected group compared to controls
(HIV+ 0.30, HIV-1.44, p = 0.03), thus confirming the relative
depletion of CD4+ single positive T cells and the corresponding
enrichment of CD8+ single positive T cells in HIV-infected
thymuses.
Figure 1. Flow cytometry analysis of thymocytes. Thymocytes were characterized by their forward (FSC) and side scattering (SSC) properties(A).
Thymocytes were gated by their CD3+ expression and SSC characteristics (B) in CD3 High(gate F), CD3 low (gate G), CD3 neg (gate H). Dot plots CD3
High DP and SP (C) CD3 low DP (D) and CD3 neg TN and ISP (E) thymocytes are showed. DP=double positive; TN= triple negative; SP = single positive;
ISP:immature single positive (CD4+).
doi:10.1371/journal.pone.0010788.g001
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Taken together, these results indicate that there was active
thymopoiesis in thymic tissues isolated from HIV-infected individuals.
However, thymic processes in HIV-infected subjects appear to be
characterized by a less-extensive expression of CD4-positive cells and
a compensative bias toward a CD8-positive pattern.
Immune activation and proliferation of thymocytes
Immune activation was measured by expression of CD27 [29]
and CD69 on thymocytes (figure 3). A trend toward higher levels
of CD27 expression was seen in HIV-infected individuals
compared to HIV-negative subjects. This was observed both in
triple negative cells (HIV+ 6%; HIV- 0.625%, p = 0.05), in CD3+
double positive cells (HIV+ 4.7%; HIV- 1.25%) and in single
positive cells (SP4+ HIV+ 10.2%, HIV- 1%; SP8+ HIV+11%,
HIV-1.6%, p = 0.03). A similar trend was observed when
expression of CD69 was analyzed. HIV-infected subjects had
higher percentages of CD69 expression in TN thymocytes (HIV+
5.5%, HIV- 0.5%) and in single positive CD8+ cells (HIV+ 7.9%;
HIV- 0.6%; p = 0.02) compared to HIV-uninfected controls.
Our results showed that, despite an apparently similar rate of
thymopoiesis, thymic tissues of HIV-infected subjects are charac-
terized by thymocyte immune hyperactivation involving either
mature T cells or T cells actively undergoing thymopoiesis.
Ex-vivo staining of thymocyte subsets with Ki67 antibodies
confirmed previous data showing the presence of extensive
thymocyte proliferation in both HIV-infected and HIV–uninfect-
ed thymuses. However, significantly higher levels of Ki67
thymocytes were detected in triple negative cells (HIV+ 39.5%,
HIV- 17.2%, p = 0.04) of HIV-infected subjects and at each
subsequent stage of thymopoiesis (CD3-DP HIV+ 59.5%, HIV-
20.55%, p = 0.04; CD3+DP HIV+ 36.35%, HIV-11.45%,
p = 0.04; SP4+ HIV+ 5.65%, HIV- 0.45%, p = 0.04; SP8+
HIV+ 15.9%, HIV- 1.15%, p = 0.02) (figure 4A).
Overall, our data show that, as opposed to HIV- controls, T-cell
activation and proliferation is higher in HIV-infected thymuses
and involves both early-stage thymocytes and mature thymocytes.
Interleukin-7 (IL-7) receptor expression on thymocytes
IL-7 signalling via the IL-7 receptor plays a critical role in
thymocyte development. Because of this, CD127 expression on
different thymocyte subsets was deemed to be important and
therefore evaluated. Interestingly, HIV-infected subjects displayed
lower levels of CD127 expression on triple negative cells (HIV+
0.5%, HIV- 2.95%), thus suggesting a possible impairment of IL-7
signalling in HIV-infected thymocytes during the earlier intrathy-
mic maturation stages or, otherwise, an increase binding of IL-7.
However, expression of CD127 on later thymopoietic stages was
higher in HIV-infected individuals compared to results obtained in
HIV-negative controls (CD3+DP HIV+ 2.3% HIV- 1.3%;
SPCD4+ HIV+ 5.8%, HIV-4.6%), suggesting a maintenance of
an IL-7 compensatory feedback in HIV infection.
Expression of chemokine receptors on thymocytes
Thymocytes were stained with CCR5- and CXCR4- specific
MAb. In HIV-infected and HIV-uninfected thymuses, CXCR4 was
expressed on the majority of thymocytes both in immature stages and
in more mature cells. However, analysis of CCR5 expression revealed
higher levels of CCR5 on CD3+DP (HIV+ 2.2%, HIV- 0.7%) and
SPCD8+ thymocytes (HIV+ 4.71%, HIV-1.7%) in HIV-infected
thymus compared to uninfected controls, suggesting a possible role by
higher immune activation status in the induction of a more consistent
expression of CCR5 on thymocytes.
Figure 2. Flow cytometry evaluation of thymopoietic stages in HIV-infected (grey triangles) and uninfected controls (white circles).
All thymopoietic stages were detected in both HIV+ and HIV- thymic tissues, but these stages were skewed in HIV-infected compared to uninfected
thymuses. Thus, whereas the percentage of immature triple negative cells (CD3-CD4-CD8-, TN) and of immature single positive CD4+ cells (ISP4+) was
comparable in HIV+ and in HIV- patients, an increase of CD3+CD4-CD8+ single positive (SP8+) cells (46.0% versus 22.5%) as well as a reduction of
double-positive (DP) (CD3brightCD4+CD8+: 23.0% versus 31.05%) and CD3+CD4+CD8- single positive (SP4+) cells (13.9% versus 37.7%) were
observed in HIV+ compared to HIV- subjects.
doi:10.1371/journal.pone.0010788.g002
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Alpha/beta and gamma/delta TCR expression on
thymocytes
Differentiation of precursors into mature T cells involves a series
of lineage switch-points. These include committing or not
committing to the T-cell fate; differentiating or not differentiating
into ab or cd lineage T cells; and, for an ab T cell, becoming
either a helper (CD4+) or a cytotoxic (CD8+) T cell.
Expression of ab TCR was significantly higher in CD3+DN
thymocytes of HIV+ individuals compared to HIV-negative
controls (HIV+ 27.5%, HIV-2.95%, p = 0.02).
cd TCR was expressed on a minority of thymocytes in both
groups of subjects and no differences were observed for various
stages of thymopoiesis in HIV-infected compared to HIV–
uninfected subjects, suggesting minimal impact from HIV on this
thymocyte population, despite its known reputation as a potential
target of HIV infection.
Regulatory T cells
Thymocytes obtained from HIV-infected and uninfected
controls were cell surface stained with antibodies to CD25,
CD3, CD4 and CD8 prior to intracellular staining of FoxP3 to
identify Treg subpopulation.
Expression of CD25 and FoxP3 on CD4+ SP cells was
significantly increased in thymuses of HIV-infected individuals
compared to uninfected controls (HIV+ 4.3%, HIV- 1.3%,
p = 0.05), while the expression of CD25 and FoxP3 on
CD4+CD8+ DP cells was comparable (HIV+ 0.22%, HIV-
0.19%) (figure 4B).
These data demonstrate that HIV induces an increase in Treg
frequency, particularly in committed CD4 single positive cells.
Possibly, this is a result of enhanced Treg survival and function caused
by direct infection. Alternatively, it could be connected to bystander
effect, mediated by host-derived pro-inflammatory molecules.
Associations between thymocyte activation, presence of
CD4+ and CD8+ single positive thymocytes, CCR5
expression and peripheral CD4+ cell count in HIV-
infected patients
To evaluate if the higher levels of thymocyte activation and
proliferation found in HIV-infected individuals may result in
Figure 3. Expression of CD69, CD27 and Ki67 on thymocytes in HIV-infected (grey triangles) and uninfected controls (white circles).
HIV-infected subjects showed significantly higher percentages of CD69(a) expression in single positive CD8+ cells (HIV+ 7.9%; HIV- 0.6%; p = 0.02)
compared to HIV-uninfected controls. A similar trend toward higher levels of CD27 (b) expression was seen in HIV-infected patients compared to HIV-
negative subjects. This was observed in triple negative cells (HIV+ 6.0%; HIV- 0.625%, p = 0.05), in CD3+ double positive cells (HIV+ 4.7%; HIV- 1.25%),
and in single positive cells (SP4+ HIV+ 10.2%, HIV- 1.0%; SP8+ HIV+11.0%, HIV-1.6%, p = 0.03). Significantly higher levels of Ki67 thymocytes (c) were
detected in triple negative cells (HIV+ 39.5%, HIV- 17.2%, p = 0.04) and in double positive and CD8+ single positive cells of HIV-infected patients
compared to uninfected controls (CD3+DP HIV+ 36.35%, HIV-11.45%, p= 0.04; SP4+ HIV+ 5.65%, HIV- 0.45%, p = 0.04; SP8+ HIV+ 15.9%, HIV- 1.15%,
p = 0.02).
doi:10.1371/journal.pone.0010788.g003
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higher susceptibility to viral infection and exhaustion of regener-
ative capacity, we investigated if in HIV-infected individuals the
fraction of activated/proliferating thymocytes correlate with (i) the
lower fraction of CD4+SP and the lower CD4+SP/CD8+SP ratio
in the thymus, (ii) increased fraction of thymocytes expressing
CCR5, and (iii) CD4+ T-cell count in blood.
In HIV-infected patients, a significant inverse correlation was seen
between the expression of Ki67 on triple negative cells and CD4
single positive thymocyte proportion (r =20.98, p,0.01), thus
confirming the association between thymocyte activation and
exhaustion of regenerative capacity. Activation of double-positive
and CD4 single positive cells, represented by CD69 expression, was
associated with peripheral CD4 T cell count (CD69+DP r = 0.85,
p = 0.01; CD69+SP4+ r = 0.82, p = 0.02). The expression of CD27
on SP thymocytes was positively associated with CCR5 expression,
reaching statistical significance for CD8+ SP cells (r = 0.87, p = 0.05).
Discussion
We investigated thymopoiesis in HIV-1 infected and healthy
adults by performing ex-vivo analyses on thymuses obtained from
either HIV-infected or HIV-uninfected individuals. Our data
indicate that HIV-infection does not impair thymopoiesis per se,
but rather induces increased proliferation and activation of
thymocytes which may, in the long term, cause clonal exhaustion
of T cells and inflammatory damage to lymphoid tissue.
There is considerable evidence indicating that HIV can infect
the thymus, both in vitro and in vivo, compromising the integrity of
this immune organ [30–32]. Studies of CD4+ T cell depletion and
reconstitution in HIV infection have delineated a multifactoral
model of immune homeostasis in which composition of naı¨ve and
memory/effector pools in blood and lymphoid tissue, thymic function
and effects of clinical stage of the disease play a significant role
[33]. Current observations have led to a general consensus that
CD4 and CD8 T cell activation and turnover are heightened in
HIV infection, that HIV infection leads to increased death of
CD4+ T cells, that there is a defect in the renewal/replacement
mechanisms for CD4+ T cells and that these replacement
mechanisms have both peripheral and thymic components.
By studying thymic cells’ phenotype of HIV-infected patients
and comparing them to healthy controls, we reasoned that if HIV
infection induced thymic alterations either through direct lysis or
through bystander action, we would be able to detect this effect by
analyzing markers of T cell differentiation and activation.
Measures of thymopoiesis indicate the presence of active
thymopoiesis in thymic tissues isolated from HIV-infected patients,
confirming previous evidence that the thymuses of HIV-positive
adult patients can engage in thymopoiesis even after prolonged
periods of CD4+ T lymphopenia [34–38]. Although immature
intrathymic precursors were equally represented in HIV-infected
and uninfected patients, HIV-infected thymuses showed less-
extensive expression of mature CD4-positive cells and a compen-
sative bias toward a CD8-positive pattern. Possibly, these data
represent an indirect marker of CD4-expressing thymocyte
destruction by HIV. They also support the role of the thymic
component in reducing input of naı¨ve CD4 T cells into the
peripheral naı¨ve T cell pool.
A clear result emerging from this study is the significantly
higher proportion of activated and proliferating thymocytes, at
all stages of thymopoiesis, in HIV-infected patients compared to
controls. Recent discoveries have produced a general consensus
that chronic systemic immune activation is a pathognomic
feature of progressive HIV infection, detrimental to HIV-
infected persons [9–11]. It is one of the strongest predictors of
disease progression, associated with impaired immune reconsti-
tution in patients on ART. It is also a critical factor which
distinguishes pathogenic from non-pathogenic simian immuno-
deficiency virus infection in nonhuman primates. Significantly,
the consequences of immune activation in HIV infection may go
far beyond the simple loss of virus-specific CD8+ T cells and
bring about a global decline of immune resources. In particular,
at the thymic site, immune activation likely caused by bystander
mechanisms and sustained by homeostatic proliferation, can
produce at least two crucial consequences: generation of
activated T cell viral targets, which drives additional viral
replication, and inflammatory damage, which may induce long-
term thymic dysfunction.
Figure 4. Expression of CD25 and FoxP3 on CD4+ SP and CD3+DP thymocytes in HIV-infected (grey triangles) and uninfected
controls (white circles). The expression of CD25 and FoxP3 on CD4+ SP cells was significantly increased in thymuses of HIV-infected individuals
compared to uninfected controls (HIV+ 4.3%, HIV- 1.3%, p= 0.05), whereas the expression of CD25 and FoxP3 on CD4+CD8+ DP cells was comparable
in the two groups of subjects (HIV+ 0.22%, HIV- 0.19%).
doi:10.1371/journal.pone.0010788.g004
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Our data also indicate dichotomous behaviour of the IL-7/IL-
7R circuit in HIV-infected thymic tissue. IL-7R expression was
found to be lower in early intrathymic maturation stage
lymphocytes (CD34+CD3-CD4-CD8-) from HIV-infected pa-
tients, a thymic subpopulation previously identified as one of the
most responsive to the lymphopoietic signal of IL-7 [26]. Possibly
this reflects a dysfunction in IL-7Ra modulation positively
correlated to specific surrogate markers of disease progression.
Nonetheless, increased expression of IL-7R in both DP and SP
cells from HIV-infected thymus could be a consequence of higher
IL-7 peripheral concentration, suggesting maintenance of effective
IL-7 compensatory feed-back loop.
In order to better understand the mechanism of R5 and X4
HIV-pathogenesis in the human thymus, we sought to quantify the
extent of CCR5 and CXCR4 expression on HIV infected human
thymocytes. Through phenotypic approach, we discovered that
freshly isolated thymocytes from HIV-infected patients have
significantly higher expressions of CXCR4 than of CCR5,
confirming previous observations about HIV-uninfected human
thymus [39]. However, HIV-infected thymus cells also displayed a
consistent trend toward higher levels of CCR5 in mature
thymocytes compared to uninfected controls. This suggests that
higher immune activation status plays an important role in the
inducement of consistent expression of CCR5 on thymocytes.
Interestingly, our data, revealing predominantly CXCR4
expression on thymocytes obtained from HIV-infected patients,
fail to explain previous studies which found that R5-HIV-1 clones
are capable of depleting the vast majority of CD4+ thymocytes
from infected SCID-hu thymus-liver grafts [40]. Rather, our data
support the hypothesis of a central role of the thymus in the
emergence of CXCR4-using quasispecies.
HIV induces abnormal development of Treg in the thymus, by
direct infection or by enhancement of their survival and function,
mediated by host-derived pro-inflammatory molecules. This
enrichment in Treg parallels a similar trend in lymphoid tissue.
Previous studies, in fact, found that chronic HIV infection changes
Treg cell tissue distribution by increasing CD4+CD25+ in
peripheral lymph nodes and mucosal lymphoid tissues, the sites
where most HIV replication occurs [41–43]. In turn, these cells
might then play a role in the creation and/or maintenance of an
environment in lymphoid tissues and in the thymus which would
favour HIV survival and persistence by impairing protective
immune responses.
In conclusion, our data support an immunopathogenic model in
which the effect of HIV upon the thymus occurs through at least
three mechanisms: (i) direct viral lysis which induces T-cell
depletion with a preferential effect on CD4+-expressing thymo-
cytes, (ii) bystander activation which involves all thymopoietic
stages, resulting in high turnover, higher susceptibility to viral
infection and exhaustion of regenerative capacity, (iii) enrichment
of Treg in the thymus possibly leading to the suppression of
pathogen-specific immunity and contributing to lack of control of
HIV.
The fact that we found active thymopoiesis in thymic tissues
isolated from HIV-infected patients despite prolonged CD4 T
lymphopenia, supports the need for further investigation into
strategies for the manipulation of thymic function, since true
thymic reconstitution would allow repair of T-cell receptor defects
that have proved recalcitrant to therapeutic intervention thus far.
The key role of T-cell activation in HIV-infected thymus in
causing CD4+ thymic precursors depletion strongly indicates the
need for immunological strategies aimed at targeting the pool of
latently infected cells that constitute the reservoir for replication
competent virus. Equally important is the necessity to develop new
techniques for decreasing cellular activation, thereby reducing the
number of cells targetable by the virus.
Enhancing thymic function, together with suppression of
immune activation and manipulation of Treg function will be
essential to restoring the function and breadth of the T-cell
compartment of the cellular immune system during HIV-1
infection.
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